These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30763263)

  • 1. Evaluation of procalcitonin immunoassay concordance near clinical decision points.
    Chambliss AB; Hayden J; Colby JM
    Clin Chem Lab Med; 2019 Aug; 57(9):1414-1421. PubMed ID: 30763263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays.
    Lippi G; Salvagno GL; Gelati M; Pucci M; Lo Cascio C; Demonte D; Faggian D; Plebani M
    Clin Chem Lab Med; 2019 Dec; 58(1):77-84. PubMed ID: 31539351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of procalcitonin assay on the Abbott Architect i2000 SR® analyzer].
    El Mouatani A; Rotaru I; Beaudeux JL; Hennequin C
    Ann Biol Clin (Paris); 2018 Jun; 76(3):308-312. PubMed ID: 29622524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter comparison of automated procalcitonin immunoassays.
    Dipalo M; Guido L; Micca G; Pittalis S; Locatelli M; Motta A; Bianchi V; Callegari T; Aloe R; Da Rin G; Lippi G
    Pract Lab Med; 2015 Aug; 2():22-28. PubMed ID: 28932801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance of Three Automated Procalcitonin Immunoassays at Medical Decision Points.
    Cho HW; Kim SH; Cho Y; Jeong SH; Lee SG
    Ann Lab Med; 2021 Jul; 41(4):419-423. PubMed ID: 33536362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays.
    Wang D; Caddell B; Nolte FS; Babic N
    J Appl Lab Med; 2019 Jan; 3(4):580-586. PubMed ID: 31639727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Procalcitonin Assay on the Abbott Architect i1000.
    Pagaduan JV; Tam E; Devaraj S
    J Appl Lab Med; 2019 May; 3(6):936-942. PubMed ID: 31639685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Siemens Atellica BRAHMS and the Abbott Architect BRAHMS Procalcitonin Assays.
    Walker C; Shuster A; Weber C; Gebhardt K; Scheidegger M; Swartzwelder J; Williams J; Li J
    Ann Clin Lab Sci; 2021 Mar; 51(2):241-244. PubMed ID: 33941564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor.
    Ceriotti F; Marino I; Motta A; Carobene A
    Clin Chem Lab Med; 2017 Nov; 56(1):162-169. PubMed ID: 28809746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. As a Novel Procalcitonin Assay is Architect B∙R∙A∙H∙M∙S PCT; Comparison of Two Commercial Systems.
    Aydemir Ö; Karakeçe E; Köroğlu M; Aydemir Y; Terzi HA; Erkorkmaz Ü; Altindiş M
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term stability of procalcitonin in frozen samples and comparison of Kryptor and VIDAS automated immunoassays.
    Schuetz P; Christ-Crain M; Huber AR; Müller B
    Clin Biochem; 2010 Feb; 43(3):341-4. PubMed ID: 19747473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the novel ARCHITECT procalcitonin assay with established procalcitonin assay systems.
    Soh A; Binder L; Clough M; Hernandez MH; Lefèvre G; Mostert K; Nguyen TB; Otte KM; Portakal O; Sandri MS; Yen JL; Huang J; Beshiri A
    Pract Lab Med; 2018 Nov; 12():e00110. PubMed ID: 30519621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a fully automated procalcitonin chemiluminescence immunoassay.
    Hubl W; Krassler J; Zingler C; Pertschy A; Hentschel J; Gerhards-Reich C; Mack M; Demant T
    Clin Lab; 2003; 49(7-8):319-27. PubMed ID: 12908732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a novel automated DiaSys procalcitonin immunoassay with four different BRAHMS-partnered immunoassays.
    Eidizadeh A; Wiederhold M; Schnelle M; Binder L
    Pract Lab Med; 2022 May; 30():e00274. PubMed ID: 35465623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical and clinical performance of the Advansure i3 procalcitonin assay.
    Heo W; Park HD
    Scand J Clin Lab Invest; 2021 Nov; 81(7):546-551. PubMed ID: 34601986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical evaluation of the novel VITROS BRAHMS procalcitonin immunoassay.
    Dupuy AM; Bargnoux AS; Montagnon V; Kuster N; Badiou S; Cristol JP
    Scand J Clin Lab Invest; 2020 Nov; 80(7):541-545. PubMed ID: 33124916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host response biomarkers in sepsis: the role of procalcitonin.
    Vincent JL; Van Nuffelen M; Lelubre C
    Methods Mol Biol; 2015; 1237():213-24. PubMed ID: 25319789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin measurement for detection of serious bacterial infection in febrile children: comparison between two automated immunoassays.
    Lacroix L; Manzano S; Galetto A; Gervaix A
    Clin Biochem; 2012 May; 45(7-8):593-5. PubMed ID: 22386955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin measurement in routine emergency medicine practice: comparison between two immunoassays.
    Hausfater P; Brochet C; Freund Y; Charles V; Bernard M
    Clin Chem Lab Med; 2010 Apr; 48(4):501-4. PubMed ID: 20148728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.